Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Long-Term Safety of SK-0403 Monotherapy in Type 2 Diabetes
jRCT2080220750Phase 3
- Sponsor
- Kowa Company, Ltd.
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of anagliptin in type 2 diabetes mellitus (T2DM), sponsored by Kowa Company, Ltd.
02
Drugs
anagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080220750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220750.